Latest Olmesartan Stories
LONDON, April 16, 2015 /PRNewswire/ -- SummaryGBI Research, the leading business intelligence provider, has released its latest research, ''Antihypertensive Therapeutics in
New research report “Anti-Hypertensive Therapeutics in Major Developed Markets to 2020 – Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries” elaborated by
The San Diego injury law firm comments on Mayo Clinic Proceedings regarding Benicar case studies, in light of a recent lawsuit filed against Benicar's manufacturer, Daiichi Sankyo, for alleged
PARSIPPANY, N.J., Jan. 9, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc. ("the Company") announced today that it has reached a civil settlement with the U.S.
NEW YORK, Oct.
New York Law Firm States That the FDA Announces Health Risks Involved with Patients Who Have Taken Benicar Commack, New York (PRWEB) August 20, 2014
Benicar Lawsuit News: According to the FDA, Benicar Is Associated With Severe Gastrointestinal Disorder Called Sprue-Like Enteropathy, Which Can Cause Chronic Diarrhea, Rapid Weight Loss, Vomiting,
Have you experienced intestinal problems after taking Benicar, Azor or Tribenzor? There are current lawsuits being filed on behalf of victims. Toledo, OH (PRWEB)
Kristine Kraft of Schlichter, Bogard & Denton, LLP reports that a French study involving the blood pressure medication Benicar® was recently discussed during the annual Digestive Disease
On June 24, the FDA communicated that there is no clear evidence of increased cardiovascular risks associated with use of Olmesartan in diabetic patients.
- Emitting flashes of light; glittering.